Wolfgang Seibold
CFO & Partner
Munich, Germany

Experienced VC and PE investor across all stages with dedication to transformative technologies; passionate networker, initiative taker and growth manager; trusted advisor to multiple start-ups, large corporations and industry associations.
As Partner and CFO of Hitachi Ventures, Wolfgang has been a driving force since the formation of Hitachi Ventures, and has led many of its investments in Digital, DeepTech and Healthcare.
Wolfgang has managed and run successful international VC and Private Equity funds for over two decades. Prior to Hitachi Ventures he was Managing Partner for AGIC Capital, a billion-dollar PE fund investing in Industrial, Medical and Digital Technologies. And before that he was a partner at Earlybird, investing in Fintech, B2B SaaS, Semiconductor and Environmental Technologies.
For many years Wolfgang served on boards of industry associations such as the German Venture Capital and Private Equity Association (BVKAP), Munich Network, CTI Invest and others.
Wolfgang studied Physics and Mathematics in Ulm, Germany and Newcastle upon Tyne, UK, and has an MBA from INSEAD in France. He started his professional career as a consultant at BCG.
Personal Notes
Through his profession, Wolfgang encounters the greatest innovations and the most impressive founders every day. This has taught him a lot of respect for every person he meets and keeps him curious. His wonderful family, long hikes and working with wood, steel and stone keep him grounded.
Active Investments
Rescale
Taranis
Huma
I Peace
Arsenal Biosciences
Scipher Medicine
Thea Energy
StrikeReady
Cure51
Relation Tx
Grow
Bioptimus
Previous
Smava
NFON
Traxpay
Myriad Software
Oneshield
Ubitricity
UPEK
Krauss Maffei
-
StrikeReady Raises $12 Million for Industry-First AI Security Command Platform Purpose-Built for Modern SOC Teams
-
Thea Energy raises $20M Series A for pixel-inspired fusion power plants
-
Scipher Medicine Receives Medicare Coverage for PrismRA® Test in Rheumatoid Arthritis Patients
-
Scipher Medicine Closes $110 Million Financing
-
The Galien Foundation Honors Excellence in Scientific Innovation at 2021 Prix Galien Awards Gala
-
IPO of our portfolio company Sophia Genetics on July 24th, 2021.
-
Hitachi Ventures investing in Huma
-
Sophia Genetics announces collaboration with Hitachi Ltd.
-
Hitachi Ventures investing in Rescale
-
Hitachi Ventures investing in Sophia Genetics.
-
Hitachi Ventures investing in Taranis.